Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day

View Full Size 

Download

• Full Size JPEG, 1600x900, 370.0 KB
• Small JPEG, 480x270, 73.8 KB
• Preview JPEG, 144x81, 10.7 KB
• Thumbnail JPEG, 72x41, 3.6 KB